Literature DB >> 32871340

Computational methods-guided design of modulators targeting protein-protein interactions (PPIs).

Yuran Qiu1, Xinyi Li1, Xinheng He1, Jun Pu2, Jian Zhang3, Shaoyong Lu4.   

Abstract

Protein-protein interactions (PPIs) play a pivotal role in extensive biological processes and are thus crucial to human health and the development of disease states. Due to their critical implications, PPIs have been spotlighted as promising drug targets of broad-spectrum therapeutic interests. However, owing to the general properties of PPIs, such as flat surfaces, featureless conformations, difficult topologies, and shallow pockets, previous attempts were faced with serious obstacles when targeting PPIs and almost portrayed them as "intractable" for decades. To date, rapid progress in computational chemistry and structural biology methods has promoted the exploitation of PPIs in drug discovery. These techniques boost their cost-effective and high-throughput traits, and enable the study of dynamic PPI interfaces. Thus, computational methods represent an alternative strategy to target "undruggable" PPI interfaces and have attracted intense pharmaceutical interest in recent years, as exemplified by the accumulating number of successful cases. In this review, we first introduce a diverse set of computational methods used to design PPI modulators. Herein, we focus on the recent progress in computational strategies and provide a comprehensive overview covering various methodologies. Importantly, a list of recently-reported successful examples is highlighted to verify the feasibility of these computational approaches. Finally, we conclude the general role of computational methods in targeting PPIs, and also discuss future perspectives on the development of such aids.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Drug discovery; Hot spots; Peptidomimetics; Protein-protein interactions; Undruggable

Mesh:

Year:  2020        PMID: 32871340     DOI: 10.1016/j.ejmech.2020.112764

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  8 in total

1.  A review on cullin neddylation and strategies to identify its inhibitors for cancer therapy.

Authors:  Iqra Bano; Moolchand Malhi; Min Zhao; Liviu Giurgiulescu; Hira Sajjad; Marek Kieliszek
Journal:  3 Biotech       Date:  2022-03-29       Impact factor: 2.406

2.  Rapid Rational Design of Cyclic Peptides Mimicking Protein-Protein Interfaces.

Authors:  Brianda L Santini; Martin Zacharias
Journal:  Methods Mol Biol       Date:  2022

3.  Molecular insights into Mmpl3 leads to the development of novel indole-2-carboxamides as antitubercular agents.

Authors:  Rajdeep Ray; Sumit Raosaheb Birangal; Fajeelath Fathima; Helena I Boshoff; He Eun Forbes; Raghu H Chandrashekhar; Gautham G Shenoy
Journal:  Mol Syst Des Eng       Date:  2022-03-02

Review 4.  Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies.

Authors:  Mohammad Hassan Baig; Khurshid Ahmad; Jun Sung Moon; So-Young Park; Jeong Ho Lim; Hee Jin Chun; Afsha Fatima Qadri; Ye Chan Hwang; Arif Tasleem Jan; Syed Sayeed Ahmad; Shahid Ali; Sibhghatulla Shaikh; Eun Ju Lee; Inho Choi
Journal:  Front Physiol       Date:  2022-06-23       Impact factor: 4.755

5.  Exploring Molecular Contacts of MUC1 at CIN85 Binding Interface to Address Future Drug Design Efforts.

Authors:  Maria Rita Gulotta; Serena Vittorio; Rosaria Gitto; Ugo Perricone; Laura De Luca
Journal:  Int J Mol Sci       Date:  2021-02-23       Impact factor: 5.923

6.  Effect of FKBP12-Derived Intracellular Peptides on Rapamycin-Induced FKBP-FRB Interaction and Autophagy.

Authors:  Carolina A Parada; Ivan Pires de Oliveira; Mayara C F Gewehr; João Agostinho Machado-Neto; Keli Lima; Rosangela A S Eichler; Lucia R Lopes; Luiz R G Bechara; Julio C B Ferreira; William T Festuccia; Luciano Censoni; Ivarne Luis S Tersariol; Emer S Ferro
Journal:  Cells       Date:  2022-01-24       Impact factor: 6.600

7.  Mechanism of allosteric activation of SIRT6 revealed by the action of rationally designed activators.

Authors:  Shaoyong Lu; Yingyi Chen; Jiacheng Wei; Mingzhu Zhao; Duan Ni; Xinheng He; Jian Zhang
Journal:  Acta Pharm Sin B       Date:  2020-09-19       Impact factor: 11.413

8.  Untangling Dual-Targeting Therapeutic Mechanism of Epidermal Growth Factor Receptor (EGFR) Based on Reversed Allosteric Communication.

Authors:  Yuran Qiu; Xiaolan Yin; Xinyi Li; Yuanhao Wang; Qiang Fu; Renhua Huang; Shaoyong Lu
Journal:  Pharmaceutics       Date:  2021-05-18       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.